Internal Medicine

Doç. Dr. Bilgin Bahadır Başgöz

Doctor and researcher Antalya Şehir Hastanesi Antalya
Diabetes Mellitus, Type 2SepsisCOVID-19
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Diabetes Mellitus, Type 2 2 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Sepsis 2 publications
  • COVID-19 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInternal Medicinesaglik.gov.trFrom source
  • InstitutionAntalya Şehir Hastanesisaglik.gov.trFrom source
  • Area of workDiabetes Mellitus, Type 2Extracted from 2 publications · Model version —From source
  • Publications66 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-5795-533XORCIDFrom source
  • Last synchronised5 November 2026 07:28https://antalyasehir.saglik.gov.tr/TR-1060196/doktorlarimiz.html#bilgin-bahadir-basgozsaglik.gov.tr

Scientific work

Publications on Diabetes Mellitus, Type 2

66 publications

  1. The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-45869-4 PMID 42002573 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  2. Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye

    Hepatology International, 2026

    DOI 10.1007/s12072-026-11139-8 PMID 42584813 Open-access full textSource: OpenAlex

  3. Adjunctive Value of Admission CBC-Derived Inflammation Indices for Catheter-Related Bloodstream Infection in Catheter-Dependent Hemodialysis Patients: A Retrospective Case–Control Study

    Diagnostics, 2026

    DOI 10.3390/diagnostics16121907 PMID 42351565 Open-access full textSource: ORCID

  4. Preliminary Findings on the Predictive Value of Hematologic Inflammatory Indices for Survival in Treatment-Naïve Non-Metastatic Nasopharyngeal Carcinoma: A Retrospective Cohort Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15124760 PMID 42355928 Open-access full textSource: ORCID

  5. Diagnostic Performance of HbA1c for Detecting OGTT-Diagnosed Diabetes in Obese Individuals with Suspected Prediabetes

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15010374 PMID 41517626 1 citation (Europe PMC) Open-access full textSource: ORCID

  6. Altered vaspin levels in hypothyroid patients: A potential marker of metabolic dysregulation

    Medicine, 2026

    DOI 10.1097/md.0000000000047620 PMID 41650089 Open-access full textSource: ORCID

  7. Association of Fat and Muscle Mass With Overall Survival in Patients With Metastatic Prostate Cancer Treated With Enzalutamide, Abiraterone, and Docetaxel

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2025.102482 PMID 41512738 Source: ORCID

  8. Comparison of Artificial Intelligence and Guidelines in Answering Questions on Gestational Diabetes: a CLEAR Tool Analysis

    Clinical Laboratory, 2026

    DOI 10.7754/clin.lab.2025.250544 PMID 41670521 Source: OpenAlex

  9. Hematologic predictors of in-hospital mortality in chronic hemodialysis patients with catheter-related bloodstream infections

    Revista română de medicină de laborator, 2026

    DOI 10.2478/rrlm-2026-0005 Open-access full textSource: OpenAlex

  10. Orlistat Therapy Significantly Reduces the Fatty Liver Index in Patients with Obesity: A Retrospective Cohort Study

    DAHUDER Medical Journal, 2026

    DOI 10.56016/dahudermj.1843964 Open-access full textSource: OpenAlex

View all 66 publications